Preparation of blood products for transfusion: Is there a best method?

Hardwick, 2008, Blood processing, ISBT Sci Ser, 3, 148, 10.1111/j.1751-2824.2008.00195.x

Devine, 2010, Processing of whole blood into cellular components and plasma, ISBT Sci Ser, 5, 78, 10.1111/j.1751-2824.2010.01366.x

Ness, 2001, Single-donor platelets reduce the risk of septic platelet transfusion reactions, Transfusion, 41, 857, 10.1046/j.1537-2995.2001.41070857.x

Andreu, 2007, Use of random versus apheresis platelet concentrates, Transf Clin Biol, 14, 514, 10.1016/j.tracli.2008.01.004

Follea, 2011, Developing collaboration between blood establishments, suppliers and regulators: the ‘managed convergence’, Vox Sang, 101, 92

Winters, 2006, Complications of donor apheresis, J Clin Apher, 21, 132, 10.1002/jca.20039

Thomas, 2008, Blood components produced from whole blood using the Atreus processing system, Transfusion, 48, 2515, 10.1111/j.1537-2995.2008.01911.x

Sandgren, 2010, Storage of buffy-coat-derived platelets in additive solutions: in vitro effects on platelets prepared by the novel TACSI system and stored in plastic containers with different gas permeability, Vox Sang, 99, 341, 10.1111/j.1423-0410.2010.01364.x

Picker, 2007, In vitro quality of red blood cells (RBCs) collected by multicomponent apheresis compared to manually collected RBCs during 49 days of storage, Transfusion, 47, 687, 10.1111/j.1537-2995.2007.01172.x

Thomas, 2010, Double red cell concentrates – in vitro quality after delayed refrigeration, Transfus Med, 20, 315, 10.1111/j.1365-3148.2010.01008.x

Lu, 2011, Characterization of blood components separated from donated whole blood after an overnight holding at room temperature with the buffy coat method, Transfusion, 10.1111/j.1537-2995.2011.03137.x

van der Meer, 2011, Evaluation of overnight hold of whole blood at room temperature before component processing: effect of red blood cell (RBC) additive solutions on in vitro RBC measures, Transfusion, 51, 15S, 10.1111/j.1537-2995.2010.02959.x

Schrezenmeier, 2010, Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred?, Vox Sang, 99, 1, 10.1111/j.1423-0410.2009.01295.x

Jenkins, 2011, Bacterial contamination in platelets: incremental improvements drive down but do not eliminate risk, Transfusion, 10.1111/j.1537-2995.2011.03187.x

Arnold, 2006, In vivo recovery and survival of apheresis and whole blood-derived platelets: a paired comparison in healthy adults, Transfusion, 46, 257, 10.1111/j.1537-2995.2006.00709.x

Vassallo, 2006, A critical comparison of platelet preparation methods, Curr Opin Hematol, 13, 323, 10.1097/01.moh.0000239703.40297.a5

Schubert, 2011, Riboflavin and ultraviolet light treatment potentiates vasodilator-stimulated phosphoprotein Ser-239 phosphorylation in platelet concentrates during storage, Transfusion

Serrano, 2010, Plasma and cryoprecipitate manufactured from whole blood held overnight at room temperature meet quality standards, Transfusion, 50, 344, 10.1111/j.1537-2995.2009.02441.x

Cardigan, 2011, Coagulation factor content of plasma products from whole blood stored for 24 hours at ambient temperature: results from an international multicenter BEST Collaborative study, Transfusion, 51, 50S, 10.1111/j.1537-2995.2010.02963.x

Garner, 2008, Apheresis donors and platelet function: inherent platelet responsiveness influences platelet quality, Transfusion, 48, 673, 10.1111/j.1537-2995.2007.01591.x

Report of the US Department of Health and Human Services, 2011